RxDoctor Payments Data

Yashar Hirshaut

Medical Oncology · New York, NYNPI 1144372095

Payments from drug & device makers

$2,736in general payments, 2019–2025

Across 125 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$528
  • Merck$366
  • Novartis$329
  • Pfizer$235
  • Amgen$225
  • Bayer$155
  • plus $899 from 11 others

What the payments were for

  • Food & beverage$2,64697%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,736 in reported general payments places this provider in the 30th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York

Other medical oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →